Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11497737 Pharmaceutical compositions of albumin and rapamycin

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

October 28, 2020

Date of Patent

November 15, 2022

Patent Application Number

17082698

Patent Citations

US Patent 10258565 Intravascular delivery of nanoparticle compositions and uses thereof

US Patent 10328031 Methods of treating pancreatic cancer

US Patent 10413531 Methods of treating bladder cancer

US Patent 10527604 Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel

US Patent 10555912 Use of polymeric excipients for lyophilization or freezing of particles

US Patent 10660965 Methods of enhancing drug delivery and effectiveness of therapeutic agents

US Patent 10682420 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane

US Patent 10705070 Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

US Patent 10900951 Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel

US Patent 10744110 Methods of treating lung cancer

•••

Patent Citations Received

US Patent 12133844 Methods of treating epithelioid cell tumors

0

US Patent 11944708 Methods of treating central nervous system disorders via administration of nanoparticles of an mTOR inhibitor and an albumin

0

US Patent 12061183 Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug

0

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Find more entities like US Patent 11497737 Pharmaceutical compositions of albumin and rapamycin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool